Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mateus Crespo

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 10, 2024
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trialPasquale Rescigno, Nuria Porta, Laura Finneran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
Characterizing CDK12-Mutated Prostate CancersPasquale Rescigno, Bora Gurel, Rita Pereira, et al.
European Urology Oncology|May 1, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate CancerMaría Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, et al.
Nature|June 29, 2018
IL-23 secreted by myeloid cells drives castration-resistant prostate cancerArianna Calcinotto, Clarissa Spataro, Elena Zagato, et al.
Cancer Discovery|May 28, 2021
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B TrialSuzanne Carreira, Nuria Porta, Sara Arce-Gallego, et al.
Journal for Immunotherapy of Cancer|June 18, 2022
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumorsDionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal, et al.
Oncotarget|November 28, 2018
EpCAM<sup>high</sup> and EpCAM<sup>low</sup> circulating tumor cells in metastatic prostate and breast cancer patientsSanne de Wit, Mariangela Manicone, Elisabetta Rossi, et al.
International Journal of Cancer|July 15, 2018
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)Kiki C Andree, Anouk Mentink, Leonie L Zeune, et al.
Cancer Cell|March 3, 2023
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancerNicolò Bancaro, Bianca Calì, Martina Troiani, et al.
The Journal of Clinical Investigation|June 4, 2024
RNASEH2B loss and PARP inhibition in advanced prostate cancerJuliet Carmichael, Ines Figueiredo, Bora Gurel, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|May 10, 2024
Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trialPasquale Rescigno, Nuria Porta, Laura Finneran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
Characterizing CDK12-Mutated Prostate CancersPasquale Rescigno, Bora Gurel, Rita Pereira, et al.
European Urology Oncology|May 1, 2022
Immune Biomarkers in Metastatic Castration-resistant Prostate CancerMaría Dolores Fenor de la Maza, Khobe Chandran, Jan Rekowski, et al.
Nature|June 29, 2018
IL-23 secreted by myeloid cells drives castration-resistant prostate cancerArianna Calcinotto, Clarissa Spataro, Elena Zagato, et al.
Cancer Discovery|May 28, 2021
Biomarkers Associating with PARP Inhibitor Benefit in Prostate Cancer in the TOPARP-B TrialSuzanne Carreira, Nuria Porta, Sara Arce-Gallego, et al.
Journal for Immunotherapy of Cancer|June 18, 2022
Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumorsDionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal, et al.
Oncotarget|November 28, 2018
EpCAM<sup>high</sup> and EpCAM<sup>low</sup> circulating tumor cells in metastatic prostate and breast cancer patientsSanne de Wit, Mariangela Manicone, Elisabetta Rossi, et al.
International Journal of Cancer|July 15, 2018
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)Kiki C Andree, Anouk Mentink, Leonie L Zeune, et al.
Cancer Cell|March 3, 2023
Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancerNicolò Bancaro, Bianca Calì, Martina Troiani, et al.
The Journal of Clinical Investigation|June 4, 2024
RNASEH2B loss and PARP inhibition in advanced prostate cancerJuliet Carmichael, Ines Figueiredo, Bora Gurel, et al.
Pageof 6